Research Advances in the Development and Application of Myc Tag Antibodies

Research Advances in the Development and Application of Myc Tag Antibodies

 

Tag Antibodies and Myc Tag Antibodies

Tag Antibodies are highly specific immunoglobulin molecules targeting peptide or protein tags artificially introduced into recombinant proteins. These antibodies play a pivotal role in molecular biology, cell biology, and proteomics research. By specifically binding to tag sequences fused with target proteins, they enable efficient detection, purification, and localization of naturally low-expressed or functionally complex proteins, serving as indispensable tool molecules in modern life science research.

 

From a molecular recognition perspective, the antigen-binding sites (CDR regions) of tag antibodies are designed against the spatial conformation or linear epitopes of tag sequences, with specificity unaffected by the target protein's structure. Common tag sequences include hexahistidine (His-tag), glutathione S-transferase (GST-tag), Myc tag (EQKLISEEDL), Flag tag (DYKDDDDK), HA tag (YPYDVPDYA), etc. For instance, His-tag antibodies recognize the helical structure formed by six consecutive histidines, which readily chelates nickel ions (Ni²) under physiological conditions, while the antibody achieves specific binding by mimicking the metal coordination environment. GST-tag antibodies target the conserved domain of glutathione transferase, coupling protein purification and detection via glutathione affinity chromatography.

  

   

The Myc tag (EQKLISEEDL), as a classic epitope tag, has dominated immunochemical analysis since the 1985 development of murine anti-c-myc monoclonal antibodies, owing to its excellent immunogenicity and specificity. This tag offers good biocompatibility, flexibly constructed at the N- or C-terminus of recombinant proteins without affecting their native structure or function. Enabled by specific recognition of high-affinity antibodies, the Myc tag demonstrates powerful detection efficiency in techniques like Western Blot, Co-IP, and FCM, precisely analyzing expression levels and subcellular localization of recombinant proteins in prokaryotic (e.g., E. coli) and eukaryotic (yeast, insect cells, mammalian cells) expression systems. In protein purification, affinity chromatography based on the Myc tag achieves efficient target protein enrichment by conjugating specific antibodies to divinyl sulfone-activated agarose media. However, this system has significant limitations: elution relies on low pH conditions, prone to causing protein conformational changes and activity loss—technical bottlenecks restricting its widespread industrial application, thus focusing its main use cases on protein expression analysis and interaction mechanism research.

  

Molecular Recognition Mechanism of Myc Tag Antibodies

Myc tag antibodies are specific recognition tools developed against the EQKLISEEDL decapeptide (derived from amino acids 410-419 of human c-Myc protein). The 9E10 monoclonal antibody, as the first-generation Myc tag antibody prepared by hybridoma technology, forms highly specific spatial complementarity between its antigen-binding site (CDR) and the Myc tag. X-ray crystallography reveals that the heavy chain CDR3 region (ARDRGYYDYWYFDV) of 9E10 interacts critically with E412-Q413-K414-L415 of the Myc tag, where the ε-amino group of K413 forms a salt bridge with Asp101 of the antibody (contributing ~-3.2 kcal/mol to binding energy), and L414 embeds into the antibody's hydrophobic pocket (van der Waals contact area 120Ų). This specific interaction endows 9E10 with nanomolar affinity (Kd≈2.4 nM) for the Myc tag, with cross-reactivity to endogenous full-length c-Myc protein <0.1%. High-affinity variants screened by phage display (e.g., Myc4A6) further optimize binding properties, enhancing affinity 5-8-fold (Kd≈0.3 nM) while maintaining specificity, and significantly improving thermal stability (retaining >90% binding activity after 1-hour treatment at 60).

  

Antibody Performance Optimization for Diverse Applications

Myc tag antibodies have undergone systematic engineering for different experimental needs. In Western blotting, introducing stable horseradish peroxidase (HRP) conjugation technology achieves sub-nanogram-level detection sensitivity (0.1-0.5 ng) with a linear range spanning three orders of magnitude (1-1000 ng). For immunoprecipitation, IgG-type antibodies directionally conjugated to magnetic beads achieve >90% binding efficiency, yielding high-purity target proteins with mild elution (0.2 mg/mL Myc peptide competition). In live cell imaging, developed Fab fragment antibodies (molecular weight reduced to 50 kDa) and nanobodies (15 kDa) significantly improve tissue penetrability (deep tumor spheroid labeling rate increased from 30% to 80%). Notably, pH-sensitive mutant antibodies (e.g., HIS-MycAb) maintain high affinity (Kd≈1 nM) at physiological pH (7.4) but rapidly dissociate (Kd1 μM) in the low pH (5.5) endosomal environment—this property enables antibody-drug conjugates (ADCs) to efficiently release payloads within target cells, enhancing cytotoxicity 3-5-fold.

  

Current Challenges and Future Directions

Despite significant progress, Myc tag antibodies face multiple challenges. Interference from endogenous c-Myc protein in complex samples (especially in tumor samples with up to 10⁷ molecules/cell) drives the development of mutation-tolerant antibodies (e.g., K413M-specific antibodies). Channel crosstalk (>15%) caused by traditional secondary antibody amplification in multicolor imaging promotes the development of directly fluorescently labeled primary antibody systems (e.g., Alexa Fluor-conjugated antibodies). Key development directions for the next five years include: AI-assisted antibody design, predicting optimal CDR sequences via deep learning (cases of 10-fold affinity enhancement achieved); non-animal production systems, such as plant expression platforms (yield up to 5 g/L, cost reduced by 80%); dynamically responsive smart antibodies, such as light-controlled conformational switching antibodies (on/off ratio >100:1); miniaturized probe development, such as Myc antibody-based quantum dot sensors (detection limit reaching single-molecule level). With these technological advances, Myc tag antibodies will continue to serve as cornerstone tools in molecular biology research, providing more precise and reliable solutions for life science studies.

  

Click on the product catalog numbers below to access detailed information on our official website.

  

Product Information

S0B0732

Myc tag Recombinant Rabbit mAb (HRP Conjugate) (S-114-13)

Host : Rabbit

Conjugation : HRP

S0B1592

Myc tag Recombinant Rabbit mAb (PE Conjugate) (S-114-13)

Host : Rabbit

Conjugation : PE

S0B1654

Rabbit Anti-Myc Tag Magnetic Agarose

Host : Rabbit

Conjugation : Magnetic Agarose

S0B1642

Rabbit Anti-Myc tag agarose beads

Host : Rabbit

Conjugation : Agarose beads

S0B0634

Myc tag Recombinant Rabbit mAb (Alexa Fluor® 488 Conjugate) (S-114-13)

Host : Rabbit

Conjugation : Alexa Fluor® 488

S0B1831

Myc tag Recombinant Rabbit mAb (FITC Conjugate) (S-114-13)

Host : Rabbit

Conjugation : FITC

Disclaimer: This article partially utilizes artificial intelligence assistance in its creation. If any content involves copyright or intellectual property issues, please let us know and we promise to verify and remove it as soon as possible.

 

ANT BIO PTE. LTD. – Empowering Scientific Breakthroughs

At ANTBIO, we are committed to advancing life science research through high-quality, reliable reagents and comprehensive solutions. Our specialized sub-brands (Absin, Starter, UA) cover a full spectrum of research needs, from general reagents and kits to antibodies and recombinant proteins. With a focus on innovation, quality, and customer-centricity, we strive to be your trusted partner in unlocking scientific mysteries and driving medical progress. Explore our product portfolio today and elevate your research to new heights.